Purbasa Patnaik brings rigorous analytical insight to construction awards

The Irish Construction Industry Awards 2025 announces its distinguished judging panel, featuring Purbasa Patnaik, Associate Director at Exelixis. Her inclusion reflects the programme’s commitment to rigorous, diverse evaluation, extending evaluation beyond traditional construction. Ms Patnaik brings over a decade in Biologics formulation and Drug Product development, a sector renowned for innovation and exacting standards. At Exelixis, Ms Patnaik leads critical drug product development and manufacturing, managing complex projects across diverse international CDMOs. Her significant contributions at NGM Bio, directing oncology and ophthalmic biologic development, and instrumental role at Harpoon Therapeutics securing IND approval, underscore formidable experience in complex project execution and regulatory navigation. Her career at Cook Pharmica, Bayer, and Eli Lilly consistently demonstrates a drive for innovation and operational excellence. This analytical acumen and leadership in high-stakes environments will prove invaluable in assessing innovation and best practice within Ireland’s construction sector, offering an incisive perspective to identify true pioneers. Anticipation builds as the "Oscars of Ireland’s construction industry" prepares to announce its finalists. View the full list of judges on the website.